D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Clinical Heterogeneity Across Proteomic Immunophenotypes In Pulmonary Arterial Hypertension

Rationale World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) arises in the setting of various disease states, genetic mutations, and exogenous inciting stimuli. [...]immunophenotypes were similar with respect to other comorbidities (hypertension, vascular disease, tobacco,...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Main Authors: Sweatt, A, Hedlin, H, Balasubramanian, V, Hsi, A, Blum, L, Robinson, W, Nicolls, M, Rabinovitch, M, Khatri, P, Zamanian, R T
Format: Article
Language:English
Subjects:
Hypertension
Lung diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rationale World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) arises in the setting of various disease states, genetic mutations, and exogenous inciting stimuli. [...]immunophenotypes were similar with respect to other comorbidities (hypertension, vascular disease, tobacco, renal insufficiency, diabetes, asthma, specific rheumatologic diagnoses) and non-PAH therapies (immunomodulatory agents, aspirin, NSAIDs, statins).
ISSN:1073-449X
1535-4970